Universal Axon Clinical Research

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• High blood pressure2 trials
• Type 2 diabetes2 trials
• Colorectal cancer1 trial
• COPD1 trial
• Cytomegalovirus infection1 trial
• Familial hypercholesterolaemia1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Liver cirrhosis1 trial
• Lung cancer1 trial

Phase

• Phase 23 trials
• Phase 32 trials

Status

• Recruiting5 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Freenome Holdings Inc.2 trials
• Boehringer Ingelheim1 trial
• Housey Healthcare ULC1 trial
• ModernaTX, Inc.1 trial
• Novartis Pharmaceuticals1 trial
• and 1 more

Running trials

• Recruiting

  Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

  NCT07631637· Phase 2· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

  NCT07610278· Phase 2· Novartis Pharmaceuticals· Source

  Contact: Glenda Padron

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  NCT06122077· Freenome Holdings Inc.· Source

  Contact: Study Coordinator

• Recruiting

  HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

  NCT07546929· Phase 2· Housey Healthcare ULC· Source

  Contact: Luis Martinez, MD (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure2 recruiting
• Type 2 diabetes2 recruiting
• COPD1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Liver cirrhosis1 recruiting
• Lung cancer1 recruiting

Closed trials

• Terminated

  A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

  NCT05085366· Phase 3· ModernaTX, Inc.· Source

• Completed

  Prevention of Colorectal Cancer Through Multiomics Blood Testing

  NCT04369053· Freenome Holdings Inc.· Source